Hbc Financial Services, Pllc Eli Lilly & CO Transaction History

Hbc Financial Services, Pllc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 02, 2021	SELL	$180.55 - $233.54 $45,137 - $58,385	-250 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$164.32 - $212.72 $41,080 - $53,180	250 New	250 $46,000
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $238,923 - $276,358	-1,634 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $200,128 - $240,852	1,467 Added 878.44%	1,634 $51,000
Q4 2019 Feb 12, 2020	BUY	$106.92 - $132.43 $17,855 - $22,115	167 New	167 $22,000

4,010

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Hbc Financial Services, Pllc, based on Form 13F filings with the SEC.

Stay updated on Hbc Financial Services, Pllc with notifications on news.